{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:23:12Z","timestamp":1787019792918,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jsat.2021.108413","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T03:03:08Z","timestamp":1618542188000},"page":"108413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Suicidal behavior, opioid use disorder, and behavioral health treatment: Prevalence and correlates among adults in the United States 2015\u20132018"],"prefix":"10.1016","volume":"130","author":[{"given":"Mir M.","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Dubenitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2021.108413_bb0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jsat.2015.02.002","article-title":"The role of perceived need and health insurance in substance use treatment: Implications for the Affordable Care act","volume":"54","author":"Ali","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108413_bb0010","series-title":"Diagnostic and statistical manual of mental disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.jsat.2021.108413_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2017.03.011","article-title":"Frequency of prescription opioid misuse and suicidal ideation, planning, and attempts","volume":"92","author":"Ashrafioun","year":"2017","journal-title":"Journal of Psychiatric Research"},{"issue":"1","key":"10.1016\/j.jsat.2021.108413_bb0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1056\/NEJMra1802148","article-title":"Understanding links among opioid use, overdose, and suicide","volume":"380","author":"Bohnert","year":"2019","journal-title":"The New England Journal of Medicine"},{"issue":"7","key":"10.1016\/j.jsat.2021.108413_bb0025","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/add.13774","article-title":"Substance use disorders and the risk of suicide mortality among men and women in the US Veterans Health Administration","volume":"112","author":"Bohnert","year":"2017","journal-title":"Addiction (Abingdon, England)"},{"issue":"49","key":"10.1016\/j.jsat.2021.108413_bb0030","doi-asserted-by":"crossref","first-page":"15078","DOI":"10.1073\/pnas.1518393112","article-title":"Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century","volume":"112","author":"Case","year":"2015","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.jsat.2021.108413_bb0035","series-title":"Annual Surveillance Report of Drug-related Risks and Outcomes \u2014 United States Surveillance Special Report","author":"Centers for Disease Control and Prevention","year":"2019"},{"issue":"9","key":"10.1016\/j.jsat.2021.108413_bb0040","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1176\/appi.ps.201900635","article-title":"Increases in providers with buprenorphine waivers in the United States from 2016 to 2019","volume":"71","author":"Ghertner","year":"2020","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.jsat.2021.108413_bb0045","series-title":"Deaths: Leading Causes for 2017. National Vital Statistics Reports","volume":"68","author":"Heron","year":"2019"},{"key":"10.1016\/j.jsat.2021.108413_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2017.04.005","article-title":"Why aren\u2019t physicians prescribing more buprenorphine?","volume":"78","author":"Huhn","year":"2017","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"5","key":"10.1016\/j.jsat.2021.108413_bb0055","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/j.pain.0000000000000484","article-title":"Opioid dose and risk of suicide","volume":"157","author":"Ilgen","year":"2016","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.jsat.2021.108413_bb0060","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.apnu.2019.04.009","article-title":"Suicidal ideation, plan, and attempts and nonmedical prescription opioid use among U.S. adults","volume":"33","author":"Kim-Godwin","year":"2019","journal-title":"Archives of Psychiatric Nursing"},{"key":"10.1016\/j.jsat.2021.108413_bb0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.drugalcdep.2017.06.028","article-title":"Treatment use, sources of payment, and financial barriers to treatment among individuals with opioid use disorder following the national implementation of the ACA","volume":"179","author":"McKenna","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"11","key":"10.1016\/j.jsat.2021.108413_bb0070","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1176\/appi.ps.201500538","article-title":"Prescriptions filled following an opioid-related hospitalization","volume":"67","author":"Naeger","year":"2016","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.jsat.2021.108413_bb0075","series-title":"Medications for opioid use disorder save lives","article-title":"Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Committee on Medication-assisted Treatment for Opioid Use Disorder","author":"National Academies of Sciences","year":"2019"},{"key":"10.1016\/j.jsat.2021.108413_bb0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jsat.2018.12.006","article-title":"Behavioral health treatment utilization among individuals with co-occurring opioid use disorder and mental illness: Evidence from a national survey","volume":"98","author":"Novak","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108413_bb0085","doi-asserted-by":"crossref","first-page":"152135","DOI":"10.1016\/j.comppsych.2019.152135","article-title":"Prevention of suicide and reduction of self-harm among people with substance use disorder: A systematic review and meta-analysis of randomised controlled trials","volume":"96","author":"Padmanathan","year":"2020","journal-title":"Comprehensive Psychiatry"},{"issue":"50\u201351","key":"10.1016\/j.jsat.2021.108413_bb0090","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths - United States, 2010\u20132015","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"14","key":"10.1016\/j.jsat.2021.108413_bb0095","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1001\/jama.2015.10345","article-title":"Changes in substance abuse treatment use among individuals with opioid use disorders in the United States, 2004\u20132013","volume":"314","author":"Saloner","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jsat.2021.108413_bb0100","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1056\/NEJMp1804059","article-title":"Moving addiction care to the mainstream - improving the quality of buprenorphine treatment","volume":"379","author":"Saloner","year":"2018","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2021.108413_bb0105","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1370\/afm.1885","article-title":"Prescription opioid duration, dose, and increased risk of depression in 3 large patient populations","volume":"14","author":"Scherrer","year":"2016","journal-title":"Annals of Family Medicine"},{"issue":"8","key":"10.1016\/j.jsat.2021.108413_bb0110","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.3390\/ijms19082410","article-title":"The efficacy of buprenorphine in major depression, treatment-resistant depression and suicidal behavior: A systematic review","volume":"19","author":"Serafini","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.jsat.2021.108413_bb0115","series-title":"Results from the 2018 National Survey on Drug Use and Health: Mental health findings","author":"Substance Abuse and Mental Health Services Administration","year":"2019"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221001392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221001392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:53:57Z","timestamp":1760039637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547221001392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":23,"alternative-id":["S0740547221001392"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108413","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suicidal behavior, opioid use disorder, and behavioral health treatment: Prevalence and correlates among adults in the United States 2015\u20132018","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108413","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108413"}}